GT Biopharma Stock Quote GTBP - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.79

Bid

2.70

Ask

2.88

Volume

7,590

2.71 Day's Range 2.79

2.60 52 Week Range 10.6599

Market Cap

3.952M

Previous Close

2.71

Open

2.73

Last Trade

116

2.79

(formt)

Last Trade Time

Financial Volume

$ 20,958

VWAP

2.7613

Average Volume (3m)

1,554,239

Shares Outstanding

1,416,651

Dividend Yield

PE Ratio

-0.52

Earnings Per Share (EPS)

-5.36

Revenue

Net Profit

-7.6M

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gtbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $2.71. Over the last year, GT Biopharma shares have traded in a share price range of $ 2.60 to $ 10.6599.

GT Biopharma currently has 1,416,651 shares outstanding. The market capitalization of GT Biopharma is $3.84 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.52.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.01	-0.357142857143	2.8	2.88	2.69	12630	2.74245685	CS
4	-0.14	-4.77815699659	2.93	3.74	2.6	55123	2.81635325	CS
12	-0.27	-8.82352941176	3.06	10.6599	2.6	1554239	7.16328406	CS
26	-4.11	-59.5652173913	6.9	10.6599	2.6	720819	7.11843575	CS
52	-5.655	-66.9626998224	8.445	10.6599	2.6	434230	7.21853333	CS
156	-354.51	-99.2191435768	357.3	363.6	2.6	294206	48.21408529	CS
260	-162.21	-98.3090909091	165	591.993	2.6	328854	108.79321795	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.82k
RGCRegencell Bioscience Holdings Ltd	$ 15.15 (349.55%)	1.34M
ATPCAgape ATP Corporation	$ 0.2262 (58.18%)	107.32M
SLRXSalarius Pharmaceuticals Inc	$ 2.34 (51.95%)	60.04M
GSUNGolden Sun Health Technology Group Ltd	$ 7.46 (45.42%)	590.09k
FLYEFly E Group Inc	$ 1.1601 (-81.82%)	25.44M
RNAZTransCode Therapeutics Inc	$ 0.3035 (-61.70%)	9.78M
JAGXJaguar Health Inc	$ 1.755 (-58.90%)	15.47M
MIRAMIRA Pharmaceuticals Inc	$ 2.55 (-49.10%)	25.64M
IVPInspire Veterinary Partners Inc	$ 5.19 (-43.83%)	1.67M
SLNASelina Hospitality PLC	$ 0.026 (-29.73%)	220.33M
SPWRSunPower Corporation	$ 0.9514 (32.91%)	186.76M
NVDANVIDIA Corporation	$ 122.59 (-0.77%)	173.91M
ADILAdial Pharmaceuticals Inc	$ 1.3422 (26.62%)	160.04M
HOLOMicroCloud Hologram Inc	$ 0.588 (26.07%)	135.56M